Nephrol Dial Transplant (2001) 16: 1905-1909
© 2001 European Renal Association-European Dialysis and Transplant Association
Low tacrolimus concentrations and increased risk of early acute rejection in adult renal transplantation
1 School of Pharmacy, 2 Department of Medicine, University of Queensland, and 3 Department of Clinical Pharmacology, Princess Alexandra Hospital, Brisbane, Queensland, Australia
Background. A retrospective analysis was performed on adult renal transplant recipients to evaluate the relationship between tacrolimus trough concentrations and the development of rejection in the first month after transplant.
Methods. A total of 349 concentrations from 29 patients, measured by enzyme-linked immunosorbent assay (ELISA), were recorded. Based on an increased serum creatinine, 12 patients were considered to have organ rejection. Rejection was confirmed by biopsy in five of these. The median trough concentration of tacrolimus over the first month of therapy, or until the time of first rejection was compared in rejecters vs non-rejecters.
Results. Median trough concentrations of tacrolimus were found to be lower in biopsy-proven rejecters vs non-rejecters (P=0.03) and all rejecters vs non-rejecters (P=0.04). The average median concentration (±SD) in the biopsy-proven rejecter group was 5.09±1.16 ng/ml, compared to 9.20±3.52 ng/ml in the non-rejecter group. After exclusion of an outlier, the average median concentration in all rejecters was 5.57±1.47 ng/ml, compared with 9.20±3.52 ng/ml in non-rejecters. A rejection rate of 55% was found for patients with a median trough concentration between 0 and 10 ng/ml. This compared with no observed rejection in patients with a median concentration between 10 and 15 ng/ml.
Conclusion. A significant relationship exists between organ rejection and median tacrolimus trough concentrations in the first month post-transplant, with patients displaying low concentrations more likely to reject. In order to minimize rejection in the first month after renal transplantation, trough concentrations greater than 10 ng/ml must be achieved.
Keywords: adult renal transplant; concentration; biopsy-proven rejection; pharmacodynamics; tacrolimus; therapeutic drug monitoring
Correspondence and offprint requests to: Professor Susan Tett, School of Pharmacy, University of Queensland, Brisbane, QLD 4072, Australia.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  R. Borrows, G. Chusney, M. Loucaidou, A. James, S. Goel, S. Borrows, J. Van Tromp, T. Cairns, M. Griffith, N. Hakim, et al. Analysis of Factors Influencing Tacrolimus Levels and Immunoassay Bias in Renal Transplantation J. Clin. Pharmacol., August 1, 2007; 47(8): 1035 - 1042. [Full Text] [PDF]
|
|